http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009026153-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c92ebb9bf53981390468c42671ce9a33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bccddeb13d3d37f62e3f3adb812646b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f05bf07f2ece993081e7ffdf82b683a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c8d4761bd715f634ba992732a0df884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_367c4c6a30a608d6cfb201ad793c5136
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-147777
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-143333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-142222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-145555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-201666
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-173845
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2008-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72dd899cfdbd82c2ec14154d51f5543d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ef6f8f69b5223d81d60cfabc4244dab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d07546f088fd2412dce2cae720040228
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab60aef053caff6c95d2de5a76e5d285
publicationDate 2009-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009026153-A1
titleOfInvention Biomarkers for alzheimer's disease and methods using the same
abstract The present invention provides various biomarkers of Alzheimer's Disease (AD). The present invention also provides various methods of using the biomarkers, including methods for diagnosis of AD, methods of determining predisposition to AD, methods of monitoring progression/regression of AD, methods of assessing efficacy of compositions for treating AD, methods of screening compositions for activity in modulating biomarkers of AD, methods of treating AD, as well as other methods based on biomarkers of AD.
priorityDate 2007-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007166829-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007166765-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006173275-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408598248

Total number of triples: 31.